Adenosine A 2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 385, Issue 4, 2012, Pages 411-421

  Michael, Sebastian ^a   Abdel Aziz, Heba ^b   Weiser, Dieter ^b   Müller, Christa E ^c   Kelber, Olaf ^b   Nieber, Karen ^d  

^a Löwen Apotheke Waldheim   (Germany)

^b Steigerwald Arzneimittelwerk GmbH   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Adenosine receptors; Iberogast; Inflammation; Isometric contraction; TNBS; TNF

Indexed keywords

ACETYLCHOLINE; ADENOSINE A2A RECEPTOR; ANGELICA ROOT; ANGELICA ROOT EXTRACT; ANTIINFLAMMATORY AGENT; IBEROGAST; MESSENGER RNA; PEPPERMINT; PLANT EXTRACT; STW 6; UNCLASSIFIED DRUG; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; CARVI FRUCTUS; CHELIDONII HERBA; CONTROLLED STUDY; ENTERITIS; GENE EXPRESSION; IBERIS AMARA; ILEUM; INTESTINE MOTILITY; JEJUNUM; LIQUIRITIAE RADIX; MALE; MATRICARIAE FLOS; MEDICINAL PLANT; MELISSAE FOLIUM; NONHUMAN; PROTEIN EXPRESSION; RADIOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; SILYBI MARIANI FRUCTUS; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; JEJUNUM DISEASE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ENTERITIS; ILEUM; JEJUNAL DISEASES; JEJUNUM; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A2A; RNA, MESSENGER; TRINITROBENZENESULFONIC ACID;

EID: 84862855599     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-011-0714-y     Document Type: Article

References (69)

1. Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361(21):2066-2078
2. Akkari R, Burbiel JC, Hockemeyer J, Muller CE (2006) Recent progress in the development of adenosine receptor ligands as antiinflamma-tory drugs. Curr Top Med Chem 6(13):1375-1399 (Pubitemid 44144923)
3. Ammon HPT, Kelber O, Okpynyi SN (2006) Spasmolytic and tonic effect ofIberogast® (STW 5) in intestinal smooth muscle. Phyto-medicine 13(SV):67
4. Antonioli L, Fornai M, Colucci R, Ghisu N, Blandizzi C, Del Tacca M (2006) A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis. Inflamm BowelDis 12(2):117-122
5. Antonioli L, Fornai M, Colucci R, Ghisu N, Da Settimo F, Natale G, Kastsiuchenka O, Duranti E, Virdis A, Vassalle C, La Motta C, Mugnaini L, Breschi MC, Blandizzi C, Del Taca M (2007) Inhibition of adenosine deaminase attenuates inflam-mation in experimental colitis. J Pharmacol Exp Ther 322 (2):435-442 (Pubitemid 47105786)
6. Antonioli L, Fornai M, Colucci R, Ghisu N, Tuccori M, Del Tacca M, Blandizzi C (2008) Regulation ofenteric functions by adenosine: pathophysiological and pharmacological implications. Pharmacol Ther 120(3):233-253
7. Antonioli L, Fornai M, Colucci R, Awwad O, Ghisu N, Tuccori M, Del Tacca M, Blandizzi C (2011a) Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis. Eur J Pharmacol 650(2-3):639-649
8. Antonioli L, Fornai M, Colucci R, Tuccori M, Blandizzi C (2011b) Pharmacological modulation ofadenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics? Expert Opin Investig Drugs 20(6):717-721
9. Ardizzone S, Bianchi Porro G (2005) Biologic therapy for inflammatory bowel disease. Drugs 65(16):2253-2286 (Pubitemid 41571985)
10. Bamias G, Sugawara K, Pagnini C, Cominelli F (2003) The Th1 immune pathway as a therapeutic target in Crohn's disease. Curr Opin Investig Drugs 4(11):1279-1286 (Pubitemid 38100572)
11. Bilkei-Gorzo A, Abo-Salem OM, Hayallah AM, Michel K, Muller CE, Zimmer A (2008) Adenosine receptor subtype-selective antagonists in inflammation and hyperalgesia. Naunyn Schmiedebergs Arch Pharmacol 377(1):65-76
12. Buira SP, Albasanz JL, Dentesano G, Moreno J, Martin M, Ferrer I, Barrachina M (2010) DNA methylation regulates adenosine A(2A) receptor cell surface expression levels. J Neurochem 112(5):127-1285
13. Chen Y, Epperson S, Makhsudova L, Ito B, Suarez J, Dillmann W, Villarreal F (2004) Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 287(6):H2478-H2486 (Pubitemid 39557116)
14. Christofi FL, Zhang H, Yu JG, Guzman J, Xue J, Kim M, Wang YZ, Cooke HJ (2001) Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system. J Comp Neurol 439(1):46-64
15. Cronstein BN, Montesinos MC, Weissmann G (1999) Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumula-tion by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc Natl Acad Sci U S A 96(11):6377-6381 (Pubitemid 29256673)
16. Eckle T, Krahn T, Grenz A, Kohler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H, Thompson LF, Unertl K, Eltzschig HK (2007) Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosinereceptors. Circulation 115(12):1581-1590 (Pubitemid 46648643)
17. Elson CO, Sartor RB, Tennyson GS, Riddell RH (1995) Experimental models of inflammatory bowel disease. Gastroenterology 109 (4):1344-1367
18. Estrela AB, Abraham WR (2011) Adenosine in the inflamed gut: a Janus faced compound. Curr Med Chem 18(18):2791-2815
19. Ferré S, Quiroz C, Orru M, Guitart X, Navarro G, Cortés A, Casadó V, Canela EI, Lluis C, Franco R (2011) Adenosine A(2A) receptors and A(2A) receptor heteromers as key players in striatal function. Front Neuroanat 5:36-44
20. Guieu R, Dussol B, Devaux C, Sampol J, Brunet P, Rochat H, Bechis G, Berland YF (1998) Interactions between cyclosporine A and adenosine in kidney transplantrecipients. Kidney Int 53(1):200-204 (Pubitemid 28066922)
21. Gundermann KJ, Godehardt E, Ulbrich M (2003) Efficacy of a herbal preparation in patients with functional dyspepsia: a meta-analysis ofdouble-blind, randomized, clinical trials. Adv Ther 20:43-49 (Pubitemid 36554439)
22. Hasko G, Cronstein BN (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25(1):33-39 (Pubitemid 38032805)
23. Hasko G, Kuhel DG, Chen JF, Schwarzschild MA, Deitch EA, Mabley JG, Marton A, Szabo C (2000) Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent andindependentmechanisms. FASEB J 14(13):2065-2074
24. Heinle H, Hagelauer D, Pascht U, Kelber O, Weiser D (2006) Intestinal spasmolytic effects of STW5 (Iberogast®) and its components. Phytomedicine 13(SV):75-79 (Pubitemid 44816467)
25. Hohenester B, Ruhl A, Kelber O, Schemann M (2004) The herbal preparation STW5 (lberogast) has potent and region-specific effects on gastric motility. Neurogastroenterol Motil 16(6):765-773 (Pubitemid 40022784)
26. Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5(3):247-264 (Pubitemid 43336037)
27. Kelber O, Wittwer A, Lapke C, Kroll U, Weiser D, Okpanyi SN, Heilmann J (2006) Ex vivo/in vitro absorption of STW 5 (Iberogast) and its extract components. Phytomedicine 13(Suppl 5):107-113 (Pubitemid 44809869)
28. 2O. Z Kristallographie-New Cryst Struct 3:447-448
29. Klotz KN, Lohse MJ, Schwabe U, Cristalli G, Vittori S, Grifantini M (1989) 2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)-a high affinity agonist radioligand for A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 340(6):679-683 (Pubitemid 20023156)
30. Kolachala V, Asamoah V, Wang L, Obertone TS, Ziegler TR, Merlin D, Sitaraman SV (2005) TNF-alpha upregulates adenosine 2b (A2b) receptor expression and signaling in intestinal epithelial cells: a basis for A2bR overexpression in colitis. Cell Mol Life Sci 62(22):2647-2657 (Pubitemid 41721236)
31. Kolachala V, Ruble B, Vijay-Kumar M, Wang L, Mwangi S, Figler H, Figler R, Srinivasan S, Gewirtz A, Linden J, Merlin D, Sitaraman S (2008) Blockade of adenosine A2B receptors ameliorates murine colitis. Br J Pharmacol 155(1):127-137
32. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP (2006) HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 20(13):2242-2250 (Pubitemid 44953854)
33. Kuno M, Seki N, Tsujimoto S, Nakanishi I, Kinoshita T, Nakamura K, Terasaka T, Nishio N, Sato A, Fujii T (2006) Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938. Eur J Pharmacol 534(1-3):241-249 (Pubitemid 43384207)
34. Link AA, Kino T, Worth JA, McGuire JL, Crane ML, Chrousos GP Wilder RL, Elenkov IJ (2000) Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol 164(1):436-442 (Pubitemid 30013019)
35. Lomax AE, Fernandez E, Sharkey KA (2005) Plasticity of the enteric nervous system during intestinal inflammation. Neurogastroenterol Motil 17(1):4-15 (Pubitemid 40204006)
36. Madisch A, Holtmann G, Mayr G, Vinson B, Hotz J (2004a) Treatment offunctional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial. Digestion 69 (1):45-52 (Pubitemid 38332924)
37. Madisch A, Holtmann G, Plein K, Hotz J (2004b) Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Aliment Pharmacol Ther 19(3):271-279 (Pubitemid 38253501)
38. Michael S, Kelber O, Hauschildt S, Spanel-Borowski K, Nieber K (2009) Inhibition of inflammation-induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6. Phytome-dicine 16(2-3):161-171
39. Michael S, Warstat C, Michel F, Yan L, Muller CE, Nieber K (2010) Adenosine A(2A) agonist and A(2B) antagonist mediate an inhi-bition of inflammation-induced contractile disturbance of a rat gastrointestinal preparation. Purinergic Signal 6(1):117-124
40. Montesinos MC, Desai A, Cronstein BN (2006) Suppression of inflam-mation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis. Arthritis Res Ther 8(2):R53
41. Müller CE (2000) Adenosine receptor ligands-recent developments part I. Agonists. Curr Med Chem 7(12):1269-1288
42. Müller CE, Shi D, Manning M Jr, Daly JW (1993) Synthesis ofpara-xanthine analogs (1,7-disubstituted xanthines) and other xanthines unsubstituted at the 3-position: structure-activity relationships at adenosine receptors. J Med Chem 36(22):3341-3349 (Pubitemid 23335698)
43. Müller CE, Thorand M, Qurishi R, Diekmann M, Jacobson KA, Padgett WL, Daly JW (2002) Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)-and A(3)-adenosine receptor antagonists. J Med Chem 45(16):3440-3450 (Pubitemid 34824031)
44. Odashima M, Bamias G, Rivera-Nieves J, Linden J, Nast CC, Moskaluk CA, Marini M, Sugawara K, Kozaiwa K, Otaka M, Watanabe S, Cominelli F (2005) Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 129(1):26-33 (Pubitemid 41002039)
45. Odashima M, Otaka M, Jin M, Horikawa Y, Matsuhashi T, Ohba R Linden J, Watanabe S (2006) A selective adenosine A2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice. Biochem Biophys Res Commun 347(4):949-954 (Pubitemid 44118210)
46. Ohman L, Simren M (2010) Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 7(3):163-173
47. Palmer TM, Trevethick MA (2008) Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduc-tion. Br J Pharmacol 153(Suppl 1):S27-S34 (Pubitemid 351340988)
48. Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30 (9):e36
49. Pizarro TT, De La Rue SA, Cominelli F (2006) Role of interleukin 6 in a murine model ofCrohn's ileitis: are cytokine/anticytokine strate-gies the future for IBD therapies? Gut 55(9):1226-1227 (Pubitemid 44277349)
50. Puffinbarger NK, Hansen KR, Resta R, Laurent AB, Knudsen TB, Madara JL, Thompson LF (1995) Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor Mol Pharmacol 47(6):1126-1132
51. Rogachev B, Ziv NY, Mazar J, Nakav S, Chaimovitz C, Zlotnik M, Douvdevani A (2006) Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation. Kidney Int 70 (4):675-681 (Pubitemid 44215342)
52. Rosch W, Vinson B, Sassin I (2002) A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. Z Gastroenterol 40(6):401-408 (Pubitemid 34650774)
53. Rosch W, Liebregts T, Gundermann KJ, Vinson B, Holtmann G (2006) Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5. Phytomedicine 13 (Suppl 5):114-121 (Pubitemid 44816468)
54. Ryzhov S, Goldstein AE, Matafonov A, Zeng D, Biaggioni I, Feoktistov I (2004) Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J Immunol 172 (12):7726-7733 (Pubitemid 38747640)
55. Ryzhov S, Solenkova NV, Goldstein AE, Lamparter M, Fleenor T, Young PP, Greelish JP, Byrne JG, Vaughan DE, Biaggioni I, Hatzopoulos AK, Feoktistov I (2008) Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endo-thelial cells. Circ Res 102(3):356-363 (Pubitemid 351271656)
56. Sandborn WJ, Targan SR (2002) Biologic therapy of inflammatory bowel disease. Gastroenterology 122(6):1592-1608 (Pubitemid 34533555)
57. Sands WA, Martin AF, Strong EW, Palmer TM (2004) Specific inhibition ofnuclear factor-kappaB-dependent inflammatory responses by cell type-specific mechanisms upon A2A adenosine receptor gene transfer. Mol Pharmacol 66(5):1147-1159 (Pubitemid 39411055)
58. Sitkovsky M, Lukashev D (2005) Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosinereceptors. Nat Rev Immunol 5(9):712-721 (Pubitemid 43086172)
59. Stein RB, Hanauer SB (1999) Medical therapy for inflammatory bowel disease. Gastroenterol Clin North Am 28(2):297-321 (Pubitemid 29306481)
60. Sullivan GW (2003) Adenosine A2A receptor agonists as anti-inflammatory agents. Curr Opin Investig Drugs 4(11):1313-1319 (Pubitemid 38100576)
61. Sundaram U, Hassanain H, Suntres Z, Yu JG, Cooke HJ, Guzman J, Christofi FL (2003) Rabbit chronic ileitis leads to up-regulation of adenosine A1/A3 gene products, oxidative stress, and immune modulation. Biochem Pharmacol 65(9):1529-1538 (Pubitemid 36555840)
62. von Arnim U, Peitz U, Vinson B, Gundermann KJ, Malfertheiner P (2007) STW 5, a phytopharmacon for patients with functional dyspepsia: results ofamulticenter, placebo-controlled double-blind study. Am J Gastroenterol 102(6):1268-1275 (Pubitemid 46802028)
63. Voß U, Michael S, Kelber O, Weiser D, Nieber K (2011) Effects of STW 5 and STW 6 on rat ileal and colonic preparations: a comparative study. 383 (S1) 24-P045
64. Wegener T, Wagner H (2006) The active components and the pharmaco-logical multi-target principle of STW 5 (Iberogast). Phytomedicine 13(Suppl 5):20-35 (Pubitemid 44809868)
65. Wood JD (2004) Enteric neuroimmunophysiology and pathophysiolo-gy. Gastroenterology 127(2):635-657
66. Yan L, Müller CE (2004) Preparation, properties, reactions, and aden-osine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability. J Med Chem 47(4):1031-1043 (Pubitemid 38176806)
67. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K (2006) The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 116(7):1913-1923 (Pubitemid 44033315)
68. Zhong H, Belardinelli L, Maa T, Feoktistov I, Biaggioni I, Zeng D (2004) A(2B) adenosine receptors increase cytokine release by bronchial smooth muscle cells. Am J Respir Cell Mol Biol 30 (1):118-125 (Pubitemid 38085266)
69. Zhong H, Belardinelli L, Maa T, Zeng D (2005) Synergy between A2B adenosine receptors and hypoxia in activating human lung fibro-blasts. Am J Respir Cell Mol Biol 32(1):2-8 (Pubitemid 40053298)